Discovery, Biology, and Risk of Inherited Variants in Breast Cancer (DRIVE)
United States of America (USA)
1 December 2019 - 30 November 2020
Research collaboration: Discovery, Biology, and Risk of Inherited Variants in Breast Cancer (DRIVE) is a research collaboration whose article contributions are accrued to its participating partner institutions.
Discovery, Biology, and Risk of Inherited Variants in Breast Cancer (DRIVE)
Partner Institutions
Discovery, Biology, and Risk of Inherited Variants in Breast Cancer (DRIVE) is a research collaboration whose article contributions are accrued to its participating partner institutions below.
- Harvard University, United States of America (USA)
- The University of Chicago (UChicago), United States of America (USA)
- German Cancer Research Center in the Helmholtz Association (DKFZ), Germany
- University of Southern California (USC), United States of America (USA)
- Fred Hutchinson Cancer Research Center (FHCRC), United States of America (USA)
- Stanford University, United States of America (USA)
- Vanderbilt University (VU), United States of America (USA)
- The University of Utah (Utah), United States of America (USA)
- NIH National Cancer Institute (NCI), United States of America (USA)
- Strangeways Research Laboratory, University of Cambridge, United Kingdom (UK)
- Wolfson Institute of Preventive Medicine, QMUL, United Kingdom (UK)
- Genetic Associations and Mechanisms in Oncology (GAME-ON), United States of America (USA)
